褪黑素与早发性卵巢功能不全关系的研究进展

doi:10.12280/gjfckx.20230761

摘要/Abstract

摘要：

早发性卵巢功能不全（premature ovarian insufficiency，POI）是女性在40岁之前出现卵巢功能减退的临床综合征，表现为生殖和内分泌功能的减弱，是导致女性不孕的重要因素之一，但其发病机制不明、治疗手段有限。褪黑素主要是由松果体合成和分泌的神经内分泌激素，具有调节昼夜节律、抗氧化、清除自由基等作用。研究表明，褪黑素参与调节卵巢类固醇激素合成、卵泡发育、排卵和卵母细胞质量。POI动物模型研究发现褪黑素可减轻氧化应激，减少细胞凋亡，通过调节多条信号通路发挥调节卵巢功能和延缓POI的作用。临床研究表明褪黑素可改善POI患者的卵巢功能，提高妊娠率。其在辅助生殖中有潜在的应用价值，为提高POI患者的生育力提供了新的方向。

关键词: 原发性卵巢功能不全, 褪黑激素, 抗氧化剂, 不育, 女（雌）性, 生殖技术, 辅助, 氧化性应激

Abstract:

Premature ovarian insufficiency (POI) is a clinical syndrome in women who develops ovarian insufficiency before the age of 40 years, which manifests itself as a weakening of reproductive and endocrine functions, and is one of the most important factors leading to female infertility, but the pathogenesis is unknown and the treatment is limited. Melatonin is a neuroendocrine hormone mainly synthesized and secreted by the pineal gland, which exerts effects in regulating circadian rhythms, antioxidant activity, and scavenging free radicals. Studies have shown that melatonin is involved in regulating ovarian steroid hormone synthesis, follicular development, ovulation and oocyte quality. Animal models for studies of POI have found that melatonin can alleviate oxidative stress, reduce apoptosis, regulate ovarian function and delay POI through the regulation of multiple signaling pathways. Clinical studies have shown that melatonin can improve ovarian function and pregnancy rate in POI patients. Its potential value in assisted reproduction provides a new direction to improve the fertility of POI patients.

Key words: Primary ovarian insufficiency, Melatonin, Antioxidant, Infertility, female, Reproductive techniques, assisted, Oxidative stress

寿梦娜, 黄艺舟, 周坚红. 褪黑素与早发性卵巢功能不全关系的研究进展[J]. 国际妇产科学杂志, 2024, 51(2): 133-136.

SHOU Meng-na, HUANG Yi-zhou, ZHOU Jian-hong. The Relationship between Melatonin and Premature Ovarian Insufficiency[J]. Journal of International Obstetrics and Gynecology, 2024, 51(2): 133-136.

参考文献 29

[1]	Kapoor E. Premature Ovarian Insufficiency[J]. Curr Opin Endocr Metab Res, 2023, 28:100435. doi: 10.1016/j.coemr.2023.100435.
[2]	Li M, Zhu Y, Wei J, et al. The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis[J]. Climacteric, 2023, 26(2):95-102. doi: 10.1080/13697137.2022.2153033.
[3]	Panay N, Anderson RA, Nappi RE, et al. Premature ovarian insufficiency: an International Menopause Society White Paper[J]. Climacteric, 2020, 23(5):426-446. doi: 10.1080/13697137.2020.1804547. pmid: 32896176
[4]	Talpur HS, Chandio IB, Brohi RD, et al. Research progress on the role of melatonin and its receptors in animal reproduction: A comprehensive review[J]. Reprod Domest Anim, 2018, 53(4):831-849. doi: 10.1111/rda.13188. pmid: 29663591
[5]	Reiter RJ, Sharma R, Romero A, et al. Aging-Related Ovarian Failure and Infertility: Melatonin to the Rescue[J]. Antioxidants(Basel), 2023, 12(3):695. doi: 10.3390/antiox12030695.
[6]	Guo YM, Sun TC, Wang HP, et al. Research progress of melatonin (MT) in improving ovarian function: a review of the current status[J]. Aging(Albany NY), 2021, 13(13):17930-17947. doi: 10.18632/aging.203231.
[7]	Romero A, Morales-García JÁ, Ramos E. Melatonin: a multitasking indoleamine to modulate hippocampal neurogenesis[J]. Neural Regen Res, 2023, 18(3):503-505. doi: 10.4103/1673-5374.350189. pmid: 36018154
[8]	Ezzati M, Velaei K, Kheirjou R. Melatonin and its mechanism of action in the female reproductive system and related malignancies[J]. Mol Cell Biochem, 2021, 476(8):3177-3190. doi: 10.1007/s11010-021-04151-z.
[9]	Jiang Y, Shi H, Liu Y, et al. Applications of Melatonin in Female Reproduction in the Context of Oxidative Stress[J]. Oxid Med Cell Longev, 2021, 2021:6668365. doi: 10.1155/2021/6668365.
[10]	Sun TC, Li HY, Li XY, et al. Protective effects of melatonin on male fertility preservation and reproductive system[J]. Cryobiology, 2020, 95:1-8. doi: 10.1016/j.cryobiol.2020.01.018.
[11]	Ahmad SB, Ali A, Bilal M, et al. Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders[J]. Cell Mol Neurobiol, 2023, 43(6):2437-2458. doi: 10.1007/s10571-023-01324-w. pmid: 36752886
[12]	Clark KL, George JW, Przygrodzka E, et al. Hippo Signaling in the Ovary: Emerging Roles in Development, Fertility, and Disease[J]. Endocr Rev, 2022, 43(6):1074-1096. doi: 10.1210/endrev/bnac013. pmid: 35596657
[13]	Olcese JM. Melatonin and Female Reproduction: An Expanding Universe[J]. Front Endocrinol(Lausanne), 2020, 11:85. doi: 10.3389/fendo.2020.00085.
[14]	Tong J, Sheng S, Sun Y, et al. Melatonin levels in follicular fluid as markers for IVF outcomes and predicting ovarian reserve[J]. Reproduction, 2017, 153(4):443-451. doi: 10.1530/REP-16-0641.
[15]	Azandeh S, Moghadam MT, Rashno M, et al. The Effect of Different Doses of Melatonin on in Vitro Maturation of Human Follicular Fluid-Derived Oocyte-Like Cells[J]. JBRA Assist Reprod, 2022, 26(2):288-298. doi: 10.5935/1518-0557.20210086.
[16]	Riaz H, Yousuf MR, Liang A, et al. Effect of melatonin on regulation of apoptosis and steroidogenesis in cultured buffalo granulosa cells[J]. Anim Sci J, 2019, 90(4):473-480. doi: 10.1111/asj.13152. pmid: 30793438
[17]	Yang C, Liu Q, Chen Y, et al. Melatonin delays ovarian aging in mice by slowing down the exhaustion of ovarian reserve[J]. Commun Biol, 2021, 4(1):534. doi: 10.1038/s42003-021-02042-z. pmid: 33958705
[18]	Zhang L, Zhang Z, Wang J, et al. Melatonin regulates the activities of ovary and delays the fertility decline in female animals via MT1/AMPK pathway[J]. J Pineal Res, 2019, 66(3):e12550. doi: 10.1111/jpi.12550.
[19]	Ma M, Chen XY, Li B, et al. Melatonin protects premature ovarian insufficiency induced by tripterygium glycosides: role of SIRT1[J]. Am J Transl Res, 2017, 9(4):1580-1602. doi: <空> pmid: 28469767
[20]	Xu H, Bao X, Kong H, et al. Melatonin Protects Against Cyclophosphamide-induced Premature Ovarian Failure in Rats[J]. Hum Exp Toxicol, 2022, 41:9603271221127430. doi: 10.1177/09603271221127430.
[21]	Goktepe O, Balcioglu E, Baran M, et al. Protective effects of melatonin on female rat ovary treated with nonylphenol[J]. Biotech Histochem, 2023, 98(1):13-19. doi: 10.1080/10520295.2022.2075566.
[22]	Li Y, Liu H, Sun J, et al. Effect of melatonin on the peripheral T lymphocyte cell cycle and levels of reactive oxygen species in patients with premature ovarian failure[J]. Exp Ther Med, 2016, 12(6):3589-3594. doi: 10.3892/etm.2016.3833. pmid: 28105091
[23]	Fraison E, Crawford G, Casper G, et al. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review[J]. Reprod Biomed Online, 2019, 39(3):467-476. doi: 10.1016/j.rbmo.2019.04.019. pmid: 31279714
[24]	Dragojević Dikić S, Vasiljević M, Jovanović A, et al. Premature ovarian insufficiency-novel hormonal approaches in optimizing fertility[J]. Gynecol Endocrinol, 2020, 36(2):162-165. doi: 10.1080/09513590. 2019.1640203. pmid: 31311350
[25]	Blumenfeld Z. What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?[J]. Front Endocrinol(Lausanne), 2020, 11:192. doi: 10.3389/fendo.2020.00192.
[26]	Espino J, Macedo M, Lozano G, et al. Impact of Melatonin Supplementation in Women with Unexplained Infertility Undergoing Fertility Treatment[J]. Antioxidants(Basel), 2019, 8(9):338. doi: 10.3390/antiox8090338.
[27]	Zou H, Chen B, Ding D, et al. Melatonin promotes the development of immature oocytes from the COH cycle into healthy offspring by protecting mitochondrial function[J]. J Pineal Res, 2020, 68(1):e12621. doi: 10.1111/jpi.12621.
[28]	王凯娟, 朱琦, 丁丁, 等. 褪黑素用于胚胎培养对卵巢储备功能低下患者体外受精-胚胎移植治疗效果的影响[J]. 安徽医科大学学报, 2022, 57(1):6-9. doi: 10.19405/j.cnki.issn1000-1492.2022.01.002.
[29]	周丽媛, 文壹, 唐君, 等. 辅助生殖促排卵过程中使用褪黑素与治疗结局关系的Meta分析[J]. 国际生殖健康/计划生育杂志, 2021, 40(1):11-17. doi: 10.12280/gjszjk.20200396.